Outcomes from the PROSPER and SPARTAN studies at ASCO 2018
Celestia S. Higano, MD, shares the outcomes from the PROSPER and SPARTAN studies in non-metastatic castrate-resistant prostate cancer are impacting the standard of care at ASCO 2018
Author: obr
Added: 07/17/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts